Compare · HIMS vs PNTG
HIMS vs PNTG
Side-by-side comparison of Hims & Hers Health Inc. (HIMS) and The Pennant Group Inc. (PNTG): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both HIMS and PNTG operate in Medical/Nursing Services (Health Care), so they compete in similar markets.
- HIMS is the larger of the two at $6.64B, about 5.0x PNTG ($1.32B).
- Over the past year, HIMS is down 31.5% and PNTG is up 57.5% - PNTG leads by 89.1 points.
- HIMS has been more active in the news (27 items in the past 4 weeks vs 4 for PNTG).
- HIMS has more recent analyst coverage (25 ratings vs 14 for PNTG).
- Company
- Hims & Hers Health Inc.
- The Pennant Group Inc.
- Price
- $28.45-3.79%
- $37.76+2.53%
- Market cap
- $6.64B
- $1.32B
- 1M return
- -7.67%
- -6.02%
- 1Y return
- -31.54%
- +57.53%
- Industry
- Medical/Nursing Services
- Medical/Nursing Services
- Exchange
- NYSE
- NASDAQ
- IPO
- 2019
- News (4w)
- 27
- 4
- Recent ratings
- 25
- 14
Hims & Hers Health Inc.
Hims & Hers Health, Inc. operates a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals. The company offers a range of health and wellness products and services available for purchase on its websites directly by customers. It provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, as well as cosmetics and supplement products, primarily focusing on wellness, sexual health, skincare, and hair care. The company's curated non-prescription products include vitamin C, melatonin, collagen protein, biotin, and teas in the wellness category; moisturizer, fragrances, face wash, and anti-wrinkle creams in the skincare category; condoms and lubricants in the sexual health category; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care category. It also offers medical consultation services; and engages in the wholesale of non-prescription product sales to retailers. Hims & Hers Health, Inc. is based in San Francisco, California.
The Pennant Group Inc.
The Pennant Group, Inc. provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families. It also provides senior living services, such as residential accommodations, activities, meals, housekeeping, and assistance in the activities of daily living to seniors, who are independent or who require some support. As of August 9, 2021, the company operated 86 home health and hospice agencies, and 54 senior living communities in Arizona, California, Colorado, Idaho, Iowa, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, and Wyoming. The Pennant Group, Inc. was incorporated in 2019 and is headquartered in Eagle, Idaho.
Latest HIMS
- Hims Enters Australia, Marking First Expansion into the Asia-Pacific Market
- Hims Arrives in Australia, Bringing Personalised Care for Men Nationwide
- Berger Montague PC Investigates Hims & Hers Health, Inc.’s Board of Directors for Breach of Fiduciary Duty (NYSE: HIMS)
- Chief Executive Officer Dudum Andrew gifted 463,289 shares and disposed of 977,566 shares (SEC Form 4)
- Chief Policy Officer Autor Deborah M. sold $467,128 worth of shares (16,773 units at $27.85) as part of a pre-agreed trading plan, decreasing direct ownership by 26% to 48,961 units (SEC Form 4)
- Chief Financial Officer Okupe Oluyemi sold $148,111 worth of shares (4,938 units at $29.99) as part of a pre-agreed trading plan and exercised 4,938 shares at a strike of $5.01 (SEC Form 4)
- Chief Legal Officer Boughton Soleil sold $691,808 worth of shares (25,111 units at $27.55) as part of a pre-agreed trading plan, decreasing direct ownership by 7% to 313,964 units (SEC Form 4)
- Chief Legal Officer Boughton Soleil converted options into 42,261 shares and covered exercise/tax liability with 21,500 shares, increasing direct ownership by 7% to 339,075 units (SEC Form 4) to satisfy tax liability
- Chief Medical Officer Carroll Patrick Harrison converted options into 26,187 shares and covered exercise/tax liability with 10,201 shares, increasing direct ownership by 9% to 197,847 units (SEC Form 4) (for tax liability)
- Director Schultz Kare converted options into 6,623 shares, increasing direct ownership by 34% to 26,020 units (SEC Form 4)
Latest PNTG
- Pennant Group to Participate in the 2026 Jefferies Healthcare Services Conference
- EVP, GC and Corp Secy Cheney Kirk Sterling sold $53,661 worth of shares (1,393 units at $38.52) as part of a pre-agreed trading plan, decreasing direct ownership by 7% to 18,401 units (SEC Form 4)
- Chief Executive Officer Guerisoli Brent sold $165,067 worth of shares (4,285 units at $38.52) as part of a pre-agreed trading plan, decreasing direct ownership by 4% to 99,544 units (SEC Form 4)
- Chief Clinical Officer Steik Jason Paul sold $53,700 worth of shares (1,394 units at $38.52), decreasing direct ownership by 8% to 15,106 units (SEC Form 4)
- SEC Form 10-Q filed by The Pennant Group Inc.
- The Pennant Group Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits
- Pennant Reports Second Quarter 2026 Results
- Pennant Acquires River Centre Assisted Living in Tucson, Arizona
- Pennant Announces Second Quarter 2026 Earnings Release and Call
- Director Smith Barry M was granted 1,900 shares, increasing direct ownership by 2% to 102,499 units (SEC Form 4)